Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioDelivery Sciences International Inc (NASDAQ:BDSI)

2.05
Delayed Data
As of Feb 22
 +0.15 / +7.89%
Today’s Change
1.50
Today|||52-Week Range
4.39
+17.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$102.8M

Company Description

BioDelivery Sciences International, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

Contact Information

BioDelivery Sciences International, Inc.
4131 ParkLake Avenue
Raleigh North Carolina 27612
P:(919) 582-9050
Investor Relations:

Employees

Shareholders

Individual stakeholders8.90%
Other institutional30.43%
Mutual fund holders16.14%

Top Executives

Mark A. SirgoVice Chairman, President & Chief Executive Officer
Ernest R. de PaolantonioChief Financial Officer, Secretary & Treasurer
Niraj VasishtChief Technical Officer & Senior Vice President
Stephana E. PattonVice President & General Counsel
Michael BullockNational Director-Managed Markets